GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75A50122C00061MAPP BIOPHARMACEUTICAL, INC.

Overview

Award facts

Net obligations
$220.92M
$220,916,162of $942.78M potential value
Period of performance
Sep 30, 2022 to Sep 30, 2030
Ends in about 4 years
Modifications
24
Latest action Nov 9, 2026
Contract type
Definitive contract
PIID 75A50122C00061

Description of requirement

PROCUREMENT OF THERAPEUTICS FOR EBOLA, SUDAN AND MARBURG VIRUSES

Dates and value

Award date
Signed on Sep 27, 2022
Potential end of performance
Sep 29, 2032
Current value
$220,916,162Base and exercised options
Potential value (if all options are exercised)
$942,781,169

Obligations by fiscal year of action

  • FY2026: $36,129,771
  • FY2025: $49,946,602
  • FY2023: $25,066,667
  • FY2022: $109,773,122

Total across 4 fiscal years: $220,916,162

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 9, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationSAN DIEGO, CA
UEIM9V9QTHR1H28
CAGE code417U0
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationSubchapter S corporationCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Administration For Strategic Preparedness And Response
  3. OFC ASST SEC FOR PREPARENESS RES

Place of performance

Place of performance
San Diego, California 92121-3823
Congressional district (place of performance)
CA-51As reported at the time of the action

Classification and competition

Classification

Product or service (PSC)
6505DRUGS AND BIOLOGICALS (product)

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Cost plus fixed feeU
Offers received
2

Solicitation and notices

Solicitation ID
75A50121R00038(as reported)
Solicitation date
May 16, 2022

Contract details

Subcontracting plan
Plan not requiredB
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 27, 2022Base obligation at award: $109,773,122
Latest action
Nov 9, 2026 — Other administrative actionModification P00024; administrative: no change in scope or value
Latest substantive action
Jul 8, 2026 — Supplemental agreement (within scope)Modification P00021; obligation change +$3,227,479
Latest funding action
Sep 18, 2026 — Funding onlyModification P00023; obligation change +$322,131; funding only: changes obligations, not scope
Actions by type
  • Base award1
  • Other administrative action13
  • Supplemental agreement (within scope)6
  • Funding only2
  • New work added (outside scope)1
  • Change order1
  • Option exercised1
25 actions recorded, Sep 27, 2022 to Nov 9, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Mfg in U.S.D

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7505
Contracting office code
75A501
Transactions recorded under this award key
25

Funding

Funding agency code
7500
Funding sub-tier code
7505
Funding office code
750501